awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33822521-CEA92525-C373-42E9-87E1-211A1002CD9D
Q33822521-CEA92525-C373-42E9-87E1-211A1002CD9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33822521-CEA92525-C373-42E9-87E1-211A1002CD9D
Erlotinib in patients with advanced non-small-cell lung cancer: impact of dose reductions and a novel surrogate marker.
P2860
Q33822521-CEA92525-C373-42E9-87E1-211A1002CD9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33822521-CEA92525-C373-42E9-87E1-211A1002CD9D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c3d7d8f99d73fe0c985fcfc6656b81bfc4a3881b
P2860
Clinical surrogate markers of survival in advanced non-small cell lung cancer (NSCLC) patients treated with second-third line erlotinib.